The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.
As HIV drug resistance increases in low- and middle-income countries, getting people onto antiretroviral treatment means little in the long run if treatment programming is not also strengthened.
Low-level viraemia is linked to treatment failure, but we are failing to make best use of effective HIV treatment as a result of inadequate viral load monitoring.
Children and adolescents in sub-Saharan Africa need to be urgently prioritised otherwise HIV targets will not be met.
New research compares treatment outcomes of single versus multiple tablet regimes, raising questions around cost-effectiveness.
New research shows that food insecurity can impact treatment outcomes for people living with HIV and hepatitis C (HCV) co-infection.
‘Encouraging’ study casts first light on PrEP-related stigma among gay and bisexual men on dating apps, following concerns about growing negative attitudes towards PrEP users.
A global lack of HIV services specifically targeting men, and harmful masculinity norms, mean men are not being reached with HIV services. This is hampering the ambition to end AIDS by 2030.
Ahead of World AIDS Day, Avert’s Sarah Hand argues that testing services must engage men in a more meaningful way if we are to tackle the rising epidemic among young women.
Treatment Action Campaign’s Sibongile Tshabalala talks about public health activism and holding governments to account when the drugs cost too much.
Let's clear up the confusion around testing — because there’s no good reason to put off getting an HIV test